Related Experiment Video
Updated: Jun 26, 2026

Qualitative and Quantitative Analysis of Siderophore Production from Pseudomonas aeruginosa
Published on: March 15, 2024
Siderophore production by uropathogenic Escherichia coli
1Department of Microbiology, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India. drmanjulavagrali@yahoo.com
Siderophore production is a key virulence factor in Escherichia coli causing urinary tract infections (UTIs). This study found siderophore-producing E. coli strains are significantly more common in UTI patients than in healthy individuals.
Area of Science:
- Microbiology
- Infectious Diseases
- Urology
Background:
- Urinary tract infections (UTIs) are common in ambulatory medicine.
- Escherichia coli is a primary causative agent of UTIs.
- Understanding virulence factors is crucial for UTI management.
Purpose of the Study:
- To investigate siderophore production as a urovirulence factor in E. coli from UTI patients.
- To compare siderophore production rates between E. coli isolates from UTI patients and fecal samples.
Main Methods:
- Collected 160 E. coli strains from urine of diagnosed UTI patients.
- Collected 50 E. coli strains from fecal samples.
- Assessed siderophore production in all collected E. coli isolates.
Main Results:
- Siderophore production was detected in 97.5% of E. coli strains from UTI patients (156/160).
- Siderophore production was observed in only 4% of fecal E. coli isolates (2/50).
- Siderophore production is significantly more prevalent in E. coli associated with UTIs.
Conclusions:
- Siderophore production is a significant virulence factor for uropathogenic E. coli (UPEC).
- Siderophore-positive E. coli strains are strong candidates for UPEC.
- Further research is needed to apply this knowledge to UTI prevention and treatment.
More Related Videos
12:36High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils
Published on: February 9, 2019
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
Related Concept Videos
Bacterial Gastroenteritis
Stringent Response in E. coli
Production of Pharmaceuticals
Microbes and Other Elemental Cycles
Production of Antibiotics